PT3229776T - Composição farmacêutica combinando pelo menos duas nanopartícuas distintas e um composto farmacêutico, preparaçâo e suas utilizações - Google Patents
Composição farmacêutica combinando pelo menos duas nanopartícuas distintas e um composto farmacêutico, preparaçâo e suas utilizaçõesInfo
- Publication number
- PT3229776T PT3229776T PT158007773T PT15800777T PT3229776T PT 3229776 T PT3229776 T PT 3229776T PT 158007773 T PT158007773 T PT 158007773T PT 15800777 T PT15800777 T PT 15800777T PT 3229776 T PT3229776 T PT 3229776T
- Authority
- PT
- Portugal
- Prior art keywords
- preparation
- pharmaceutical
- pharmaceutical composition
- composition combining
- distinct nanoparticles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
- Y10S977/907—Liposome
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14306874 | 2014-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3229776T true PT3229776T (pt) | 2023-08-17 |
Family
ID=52013981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT158007773T PT3229776T (pt) | 2014-11-25 | 2015-11-24 | Composição farmacêutica combinando pelo menos duas nanopartícuas distintas e um composto farmacêutico, preparaçâo e suas utilizações |
Country Status (13)
Country | Link |
---|---|
US (2) | US10391058B2 (pt) |
EP (1) | EP3229776B1 (pt) |
JP (1) | JP6836510B2 (pt) |
AR (1) | AR102781A1 (pt) |
DK (1) | DK3229776T3 (pt) |
ES (1) | ES2951598T3 (pt) |
FI (1) | FI3229776T3 (pt) |
HU (1) | HUE062561T2 (pt) |
LT (1) | LT3229776T (pt) |
PL (1) | PL3229776T3 (pt) |
PT (1) | PT3229776T (pt) |
TW (1) | TW201628654A (pt) |
WO (1) | WO2016083343A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112015029853A2 (pt) * | 2013-05-30 | 2017-07-25 | Nanobiotix | uso de uma composição farmacêutica |
JP6789960B2 (ja) * | 2014-11-25 | 2020-11-25 | キュラディグム・エスアエスCuradigm Sas | 医薬組成物、その調製及び使用 |
AR102778A1 (es) | 2014-11-25 | 2017-03-22 | Nanobiotix | Composición farmacéutica, su preparación y sus usos |
EP3229776B1 (en) * | 2014-11-25 | 2023-06-28 | Curadigm Sas | Pharmaceutical composition combining at least two distinct nanoparticles and a pharmaceutical compound, preparation and uses thereof |
US11304902B2 (en) | 2014-11-25 | 2022-04-19 | Curadigm Sas | Pharmaceutical compositions, preparation and uses thereof |
AR104806A1 (es) | 2015-05-28 | 2017-08-16 | Nanobiotix | Nanopartículas para uso como vacuna terapéutica |
CN115137822B (zh) * | 2022-06-13 | 2023-06-23 | 武汉大学中南医院 | 一种光热热电一体化的抗肿瘤植入体的制备方法 |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4280918A (en) | 1980-03-10 | 1981-07-28 | International Business Machines Corporation | Magnetic particle dispersions |
GB9509321D0 (en) | 1995-05-09 | 1995-06-28 | Zylepsis Ltd | Methods of and substances for inhibiting oxidative enzymes |
AU4821697A (en) | 1996-10-18 | 1998-05-15 | Wayne State University | 6',7'-dihydroxybergamottin, a cytochrome p450 ihnibitor in grapefruit juice |
JPH10120597A (ja) | 1996-10-22 | 1998-05-12 | Eiken Chem Co Ltd | リンパ節高集積性コロイド粒子 |
BR9812131A (pt) | 1997-08-19 | 2000-07-18 | Warner Lambert Co | Composições contendo bergamotina para aumentar a biodisponibilidade oral de agentes farmacêuticos |
US7311924B2 (en) * | 1999-04-01 | 2007-12-25 | Hana Biosciences, Inc. | Compositions and methods for treating cancer |
CN1245977C (zh) * | 2000-06-30 | 2006-03-22 | 英耐克斯药品股份有限公司 | 脂质体抗肿瘤药物及其使用 |
US8178123B2 (en) | 2001-08-29 | 2012-05-15 | Femina Pharma Incorporated | Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration |
US20050090732A1 (en) | 2003-10-28 | 2005-04-28 | Triton Biosystems, Inc. | Therapy via targeted delivery of nanoscale particles |
AU2004308756B2 (en) | 2003-12-22 | 2010-06-24 | Bracco Suisse S.A. | Gas-filled microvesicle assembly for contrast imaging |
JP2007523090A (ja) * | 2004-02-10 | 2007-08-16 | バーンズ−ジューイッシュ ホスピタル | デコイ系を用いたターゲティングされた微粒子剤の有効性および安全性の改善方法 |
US20060264804A1 (en) | 2005-04-07 | 2006-11-23 | Yoram Karmon | Device and kit for delivery of encapsulated substances and methods of use thereof |
WO2006127962A2 (en) * | 2005-05-25 | 2006-11-30 | Becton, Dickinson And Comapny | Particulate formulations for intradermal delivery of biologically active agents |
DE102005039579B4 (de) * | 2005-08-19 | 2022-06-30 | Magforce Ag | Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen |
EP2000150B1 (en) * | 2006-03-24 | 2016-07-13 | Toto Ltd. | Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle |
WO2007116954A2 (en) | 2006-03-30 | 2007-10-18 | Fujifilm Corporation | Inorganic nanoparticle comprising an active substance immobilized on the surface and a polymer |
EP1852107A1 (en) | 2006-04-19 | 2007-11-07 | Nanobiotix | Magnetic nanoparticles compositions and uses thereof |
US20090181076A1 (en) | 2006-05-04 | 2009-07-16 | University Of South Australia | Drug Release From Nanoparticle-Coated Capsules |
JP2010536874A (ja) | 2007-08-21 | 2010-12-02 | アルザ・コーポレーシヨン | ボロン酸化合物をインビボ投与するためのリポソーム組成物 |
FR2922106B1 (fr) | 2007-10-16 | 2011-07-01 | Univ Claude Bernard Lyon | Utilisation de nanoparticules a base de lanthanides comme agents radiosensibilisants. |
US20100272639A1 (en) | 2007-12-21 | 2010-10-28 | John Robert Dutcher | Polysaccharide nanoparticles |
US9403789B2 (en) | 2008-02-21 | 2016-08-02 | Sequoia Pharmaceuticals, Inc. | Benzofuran-containing amino acid inhibitors of cytochrome P450 |
WO2009142754A1 (en) | 2008-05-22 | 2009-11-26 | Goverment Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Dendritic conjugates and methods of use |
EP2130553A1 (en) | 2008-06-05 | 2009-12-09 | Nanobiotix | Inorganic nanoparticles of high density to destroy cells in-vivo |
US20130023714A1 (en) | 2008-10-26 | 2013-01-24 | Board Of Regents, The University Of Texas Systems | Medical and Imaging Nanoclusters |
GB0921596D0 (en) | 2009-12-09 | 2010-01-27 | Isis Innovation | Particles for the treatment of cancer in combination with radiotherapy |
US8580312B2 (en) | 2010-02-17 | 2013-11-12 | National University Corporation Kobe University | Radiation therapy agent |
LT2552438T (lt) | 2010-03-26 | 2016-09-26 | Abraxis Bioscience, Llc | Hepatoceliulinės karcinomos gydymo būdai |
GB201009455D0 (en) | 2010-06-04 | 2010-07-21 | King S College London | Nanoparticles and their uses in molecular imaging |
WO2012051220A1 (en) | 2010-10-11 | 2012-04-19 | Wichita State University | Composite magnetic nanoparticle drug delivery system |
MX346144B (es) | 2010-12-17 | 2017-03-09 | Arrowhead Res Corp * | Porcion activadora del modulador farmacocinetico del agregado de galactosa para arnsi. |
EP2670393B8 (en) * | 2011-01-31 | 2016-10-05 | Nanobiotix | Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles. |
AU2012213538A1 (en) * | 2011-01-31 | 2013-08-15 | Nanobiotix | Nanoparticles delivery systems, preparation and uses thereof |
US10251841B2 (en) | 2011-10-17 | 2019-04-09 | Trustees Of Boston University | Polymeric depots for localization of agent to biological sites |
CN102532154B (zh) | 2012-01-11 | 2014-05-14 | 昆明医学院 | 隆萼当归线型呋喃香豆素化合物及其应用 |
US20150209397A1 (en) | 2012-09-07 | 2015-07-30 | Carnegie Mellon University | Methods and materials for reducing reticuloendothelial system clearance of particles from a subject |
ITRM20120480A1 (it) | 2012-10-09 | 2014-04-10 | Uni Degli Studi Camerino | Nanoparticelle lipidiche multicomponenti e procedimenti per la loro preparazione. |
US20140186447A1 (en) | 2012-12-28 | 2014-07-03 | Abraxis Bioscience, Llc | Nanoparticle compositions of albumin and paclitaxel |
BR112015029853A2 (pt) | 2013-05-30 | 2017-07-25 | Nanobiotix | uso de uma composição farmacêutica |
EP2886128A1 (en) | 2013-12-20 | 2015-06-24 | Nanobiotix | Pharmaceutical composition comprising nanoparticles, preparation and uses thereof |
EP3229776B1 (en) * | 2014-11-25 | 2023-06-28 | Curadigm Sas | Pharmaceutical composition combining at least two distinct nanoparticles and a pharmaceutical compound, preparation and uses thereof |
AR102778A1 (es) | 2014-11-25 | 2017-03-22 | Nanobiotix | Composición farmacéutica, su preparación y sus usos |
JP6789960B2 (ja) | 2014-11-25 | 2020-11-25 | キュラディグム・エスアエスCuradigm Sas | 医薬組成物、その調製及び使用 |
SG11201704143YA (en) | 2014-11-25 | 2017-06-29 | Nanobiotix | Pharmaceutical composition, preparation and uses thereof |
US11304902B2 (en) | 2014-11-25 | 2022-04-19 | Curadigm Sas | Pharmaceutical compositions, preparation and uses thereof |
-
2015
- 2015-11-24 EP EP15800777.3A patent/EP3229776B1/en active Active
- 2015-11-24 TW TW104139005A patent/TW201628654A/zh unknown
- 2015-11-24 PL PL15800777.3T patent/PL3229776T3/pl unknown
- 2015-11-24 PT PT158007773T patent/PT3229776T/pt unknown
- 2015-11-24 WO PCT/EP2015/077446 patent/WO2016083343A1/en active Application Filing
- 2015-11-24 LT LTEPPCT/EP2015/077446T patent/LT3229776T/lt unknown
- 2015-11-24 HU HUE15800777A patent/HUE062561T2/hu unknown
- 2015-11-24 FI FIEP15800777.3T patent/FI3229776T3/fi active
- 2015-11-24 AR ARP150103849A patent/AR102781A1/es unknown
- 2015-11-24 JP JP2017546034A patent/JP6836510B2/ja active Active
- 2015-11-24 ES ES15800777T patent/ES2951598T3/es active Active
- 2015-11-24 US US15/529,101 patent/US10391058B2/en active Active
- 2015-11-24 DK DK15800777.3T patent/DK3229776T3/da active
-
2019
- 2019-08-26 US US16/550,342 patent/US11471410B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US10391058B2 (en) | 2019-08-27 |
FI3229776T3 (fi) | 2023-08-15 |
LT3229776T (lt) | 2023-08-25 |
JP2018504450A (ja) | 2018-02-15 |
DK3229776T3 (da) | 2023-07-31 |
AR102781A1 (es) | 2017-03-22 |
TW201628654A (zh) | 2016-08-16 |
PL3229776T3 (pl) | 2023-11-06 |
US20170258717A1 (en) | 2017-09-14 |
US11471410B2 (en) | 2022-10-18 |
JP6836510B2 (ja) | 2021-03-03 |
EP3229776B1 (en) | 2023-06-28 |
WO2016083343A1 (en) | 2016-06-02 |
HUE062561T2 (hu) | 2023-11-28 |
EP3229776A1 (en) | 2017-10-18 |
US20190374465A1 (en) | 2019-12-12 |
ES2951598T3 (es) | 2023-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276695B (en) | Antibodies, pharmaceutical preparations and their uses | |
EP3179870C0 (en) | ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS AND USES THEREOF | |
IL242348B (en) | Arylquinazolines, their preparation and pharmaceutical preparations containing them | |
HK1222563A1 (zh) | 藥物組合物、製備及其用途 | |
LT3229776T (lt) | Farmacinė kompozicija, kurioje derinamos mažiausiai dvi skirtingos nanodalelės ir farmacinis mišinys, jos paruošimas ir vartojimas | |
PL3223796T3 (pl) | Kompozycje farmaceutyczne, ich wytwarzanie i zastosowania | |
IL252397A0 (en) | Pharmaceutical preparations, their preparation and uses | |
IL290114A (en) | Pharmaceutical preparations, their preparation and uses | |
EP3141243A4 (en) | Pharmaceutical composition | |
GB201506526D0 (en) | Medicinal composition | |
LT3229843T (lt) | Farmacinė kompozicija, jos paruošimo būdas ir naudojimas | |
HK1248225A1 (zh) | 二氫吡嗪並吡嗪化合物的藥物組合物、其固體形式和它們的用途 | |
GB201515310D0 (en) | Pharmaceutical composition | |
GB201520862D0 (en) | Pharmaceutical composition | |
IL262929A (en) | Preparations for treatment, methods for their preparation and their uses | |
EP3170512A4 (en) | Pharmaceutical composition | |
GB201400117D0 (en) | Pharmaceutical composition | |
IL255042B (en) | Amphiphilic compounds, their preparations and uses | |
PT3233126T (pt) | Nanopartículas para encapsular compostos, sua preparação e utilizações | |
IL284405A (en) | Pharmaceutical composition, preparation and uses thereof | |
ZA201509173B (en) | A topical medicinal composition | |
GB201521456D0 (en) | Pharmaceutical composition | |
AU2015905241A0 (en) | A Pharmaceutical Composition and Uses Therefor | |
AU2014903990A0 (en) | Pharmaceutical composition | |
TH1501007100A (th) | องค์ประกอบทางเภสัชกรรม, การเตรียม และการใช้ของมัน |